Patent details

Basic Information

Publication number:

EP2892532

PCT Application Number:

US2013058768

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137658860

PCT Publication Number:

WO2014039971

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA

French Title of Invention:

INHIBITEURS DE MET, VEGFR ET RET POUR L'UTILISATION DANS LE TRAITEMENT DE L'ADÉNOCARCINOME PULMONAIRE

German Title of Invention:

HEMMER VON MET, VEGFR UND RET ZUR VERWENDUNG IN DER BEHANDLUNG VON LUNGENADENOCARZINOM

SPC Number:

Dates

Filing date:

09/09/2013

Grant date:

13/02/2019

EP Publication Date:

15/07/2015

PCT Publication Date:

13/03/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/02/2019

EP B1 Publication Date:

13/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/09/2019

Expiration date:

09/09/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/02/2019

 

 

Name:

Exelixis, Inc.

Address:

1851 Harbor Bay Parkway, Alameda, CA 94502, United States (US)

Inventor

Name:

AFTAB, Dana, T.

Address:

United States (US)

Priority

Priority Number:

201261698143 P

Priority Date:

07/09/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201907

Publication date:

13/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages